{
  "id": 1951814,
  "title": "Amgen cans its TScan partnership; Amylyx reveals $350M offering",
  "url": "https://urgent.news/2026/08/19/amgen-cans-its-tscan-partnership-amylyx-reveals-350m-offering",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-08-19T14:43:16.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/amgen-cans-its-tscan-partnership-amylyx-reveals-350m-offering/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Plus news about BioArctic, Enveda, Georgiamune, Kynexis, Tolerance Bio and Network Bio. Amgen puts the \"can\" in TScan: Amgen is terminating its partnership with TScan Therapeutics, the Waltham, MA-based T cell therapy maker said in ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}